期刊文献+

PET-CT在乳腺癌保乳微创治疗中的应用研究 被引量:10

STUDY OF PET- CT IN THE APPLICATION OF MINIMAL INVASIVE BREAST CONSERVED THERAPY
原文传递
导出
摘要 目的:探讨PET蛳CT在早期乳腺癌保乳微创治疗中的可行性及其临床意义。方法:选取2002年12月—2004年3月行PET蛳CT检查的乳腺肿瘤或腋窝肿物患者40例(包括1例男性患者),给予常规检查及PET蛳CT扫描,根据疾病性质及患者情况给予相应手术治疗,根据术后病理结果评价PET蛳CT对于原发肿瘤及转移灶诊断的准确性,及其判断腋窝淋巴结转移情况的可行性,并与SLNB或ALND进行比较。结果:PET蛳CT诊断原发肿瘤的敏感性、特异性、准确率为95.2 %、50 %、88 %;在切检术后病例中,PET蛳CT诊断肿瘤是否残留的敏感性、特异性及准确率为25 %、83.3 %、60 %;肿瘤病理大小与PET蛳CT诊断大小相关性最为显著(Pearson系数=0.786,P=0.000);以SLNB和/或ALND作为金标准,PET蛳CT诊断腋窝淋巴结状况的敏感性、特异性及准确率是72.2 %、94.4 %、83.3 %,诊断转移淋巴结数目与病理诊断数目的符合率为41.2 %。结论:PET蛳CT与原发肿瘤病理诊断基本符合,两者诊断原发肿瘤大小一致性最佳,PET蛳CT有望成为准确判断肿瘤范围的可靠方法;但对于腋窝淋巴结,PET蛳CT尚没有足够的敏感性及准确率成为SLNB以外的准确诊断腋窝淋巴结状况的方法。 Objective: To evaluate the feasibility and clinical significance of PET- CT scan in minimal invasive breast conserved therapy of early stage breast cancer. Methods: From December 2002 to March 2004, PET- CT was performed for 40 cases with breast tumor before surgery. Accuracy of PET- CT was evaluated on pathological results and compared with SLNB or ALND. Results: The sensitivity, speciality, and accuracy of PET- CT on primary tumor were 95.2 %, 50 %, and 88 % respectively; and 72.2 %, 94.4 %, and 83.3 %, respectively for axillary lymph nodes. The pathological size of primary tumor remarkably correlated with that of PET- CT (Pearson coefficient is 0.786;P=0.000). Conclusion: PET- CT is expected to be a new method for the correct diagnosis of both primary tumor and axillary lymph nodes. With its low sensitivity and accuracy comparing with SLNB, PET- CT could not substitute SLNB for the minimal invasive therapy of axillary lymph nodes.
出处 《肿瘤研究与临床》 CAS 2004年第2期103-106,共4页 Cancer Research and Clinic
关键词 PET-CT 乳腺癌 保乳微创治疗 PET- CT Breast cancer Minimal invasive breast conserved therapy
  • 相关文献

参考文献11

  • 1赵军.PET/CT——功能与解剖结构的同机图像融合[J].国外医学(放射医学核医学分册),2000,24(6):246-249. 被引量:21
  • 2BarrangerE, GrahekD,AntoineM, etal. Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early- stage breast cancer[J]. Ann Surg Oncol,2003,10(6):622-627.
  • 3Wahl R L, Siegel B A, Coleman R E, et al. PET Study Group:Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer:, a report of the staging breast cancer with PET Study Group[J]. J Clin Oncol, 2004,22(2):27
  • 4Cox C E, Salud C J, Cantor A, et al. Learning cnrves for breast cancer sentinel lymph node mapping based on surgical volume analysis[J]. J Am Coll Surg, 2001,193(6):593-600.
  • 5Zornoza G, Gareia-Velloso M J, Sola Let al. 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast caneer[J]. Eur J Surg Oncol, 2004,30(1): 15 - 19.
  • 6Brady E W. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cance[J]. Breast J, 2002,8(2):97-100.
  • 7Donahue E J. Sentinel node imaging and biopsy in breast cancer patients[J]. Am J Surg, 2001,182(4):426-428.
  • 8HubnerKF,SmithGT,ThieJA, et al. The potential of F-18-FDG PET in breast cancer :Detection of primary lesion,axillary lymph node metastases,or distant metastases [J]. Clin Positron Imaging, 2000,3(5): 197- 205.
  • 9S Eva Singletary, Craig Allred, Pandora Ashley, et al. Revision of the American Joint Committee on cancer staging system for breast cancer[J]. J Clin Oncol,2002,20: 3628-3636.
  • 10TafraL,LanninDR,SwansonMS, eta]. Multicentertrialofsentinel node biopsy for breast cancer using both technetium sulfur colloid and isosuffan blue dye[J]. Ann Surg,2001,233:51-59.

二级参考文献1

  • 1Moshe Bocher,Adi Balan,Yodphat Krausz,Yigal Shrem,Albert Lonn,Michael Wilk,Roland Chisin. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images[J] 2000,European Journal of Nuclear Medicine(6):619~627

共引文献20

同被引文献1749

引证文献10

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部